Patents by Inventor Douwe Van Sinderen

Douwe Van Sinderen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Orally administered bacteria as vehicles for systemic delivery of agents
    Patent number: 9103831
    Abstract: The current invention relates to the use of a bacterial species in the preparation of a composition adapted for oral administration for the delivery of an agent to a site in the body. The site in the body may be an organ or a tumour site. The bacterial species is a food grade, non-pathogenic, gram-positive bacteria capable of anaerobic growth.
    Type: Grant
    Filed: July 16, 2010
    Date of Patent: August 11, 2015
    Assignee: University College Cork-National University of Ireland Cork
    Inventors: Mark Tangney, Douwe Van Sinderen, Michelle Cronin, Brendan O'Sullivan
  • ORALLY ADMINISTERED BACTERIA AS VEHICLES FOR SYSTEMATIC DELIVERY OF AGENTS
    Publication number: 20120189550
    Abstract: The current invention relates to the use of a bacterial species in the preparation of a composition adapted for oral administration for the delivery of an agent to a site in the body. The site in the body may be an organ or a tumour site. The bacterial species is a food grade, non-pathogenic, gram-positive bacteria capable of anaerobic growth.
    Type: Application
    Filed: July 16, 2010
    Publication date: July 26, 2012
    Applicant: UNIVERSITY COLLEGE CORK-NATIONAL UNIVERSITY OF IRELAND, CORK
    Inventors: Gerald O'Sullivan, Mark Tangney, Douwe Van Sinderen, Michelle Cronin
  • BIFIDOBACTERIUM LONGUM
    Publication number: 20100183559
    Abstract: The multiple embodiments described herein comprise the genome of a probiotic Bifidobacterium longum bifidobacteria strain and genes encoded by the genome. Various novel Bifidobacterium longum are described.
    Type: Application
    Filed: November 11, 2009
    Publication date: July 22, 2010
    Applicants: Alimentary Health Limited, The Procter & Gamble Company
    Inventors: Douwe Van Sinderen, Jun Xu, Wenzhu (Steven) Zhao, Raymond A. Grant, Song Yuli, Charles Bascom, Duane Larry Charbonneau, Liam O'Mahony
  • Product
    Publication number: 20050037395
    Abstract: An isolated Bifidobacteria DNA fragment comprises nucleic acid selected from sequence ID No. 1, sequence ID No. 2 or sequence ID No. 3. A protein having sequence ID No. 4, sequence ID No. 5, sequence ID No. 6, sequence ID No. 7, sequence ID No. 8 or sequence ID No. 9 is also disclosed as are DNA fragments comprising sequence ID No. 10 or 11 and proteins encoded thereby. A two-component signal transduction system comprises a gene encoding sequence ID No. 4 and a gene encoding sequence ID No. 5, a gene encoding sequence ID No. 6 and a gene encoding sequence ID No. 7 or a gene encoding sequence ID No. 8 and a gene encoding sequence ID No. 9. The Bifidobacteria may be Bifidobacterium infantis UCC35624.
    Type: Application
    Filed: June 28, 2004
    Publication date: February 17, 2005
    Inventor: Douwe Van Sinderen